Assessment of Visual Field-related Endpoints in Patients With Non-arteritic Ischemic Optic Neuropathy

NCT ID: NCT01614158

Last Updated: 2014-05-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

16 participants

Study Classification

OBSERVATIONAL

Study Start Date

2009-04-30

Study Completion Date

2011-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This present research project intends to collect five quantitative test series:

* perimetric examination using static stimuli, assessing the entire (80 degree) visual field with a fast thresholding algorithm (GATE) \[Schiefer 2008\] to know the extent/ magnitude of the visual field defect and its variability within the cohort and over time
* D-BCVA, using FrACT \[Bach 2007\] and EDTRS chart \[Ferris 1982\]
* RAPD (using swinging flashlight test).
* IOP (using applanation tonometer)
* RNFT and RNFV using Spectralis OCT (star scan, ring scan 2,8 mm, and volume scan) Optic disk morphology will be documented by fundus photography. This assessment of the above-mentioned data is needed in order to allow for estimation of the spontaneous course / fluctuation of the (quantified) functional and morphometric parameters of the N-AION patients during the follow-up period. This is essential for the estimation of the sample size of the subsequently intended SINN study, that is intended to compare different therapeutic strategies in N-AION patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Non-arteritic Ischemic Optic Neuropathy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

acute N-AION (< 7 d)

physical, intellectual and linguistic abilities, in order to understand the test requirements

* willingness to comply with the protocol (4 visits)
* 45 - 80 years, informed consent
* acute N-AION (\< 7 d)
* D-BCVA \> 0.1 (2/20)
* RAPD ≥ 0.3 logE steps (neutral density filters)

perimetry

Intervention Type DEVICE

perimetric examination using static stimuli, assessing the entire (80 degree) visual field with a fast thresholding algorithm (GATE) \[Schiefer 2008\] to know the extent/ magnitude of the visual field defect and its variability within the cohort and over time

D-BCVA

Intervention Type OTHER

D-BCVA using EDTRS chart

RAPD

Intervention Type OTHER

RAPD using swinging flashlight test

IOP

Intervention Type DEVICE

IOP using applanation tonometer

Spectralis OCT

Intervention Type DEVICE

RNFT and RNFV using Spectralis OCT (star scan, ring scan 2,8 mm and volume scan)

Fundus photography

Intervention Type OTHER

Optic disk morphology will be documented by fundus photography

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

perimetry

perimetric examination using static stimuli, assessing the entire (80 degree) visual field with a fast thresholding algorithm (GATE) \[Schiefer 2008\] to know the extent/ magnitude of the visual field defect and its variability within the cohort and over time

Intervention Type DEVICE

D-BCVA

D-BCVA using EDTRS chart

Intervention Type OTHER

RAPD

RAPD using swinging flashlight test

Intervention Type OTHER

IOP

IOP using applanation tonometer

Intervention Type DEVICE

Spectralis OCT

RNFT and RNFV using Spectralis OCT (star scan, ring scan 2,8 mm and volume scan)

Intervention Type DEVICE

Fundus photography

Optic disk morphology will be documented by fundus photography

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Static Perimetry, Octopus 101, thresholding algorithm Best Corrected Visual Acuity, EDTRS Chart SWIFT-Test intraocular pressure RNFT, RNFV, volume scan, star scan, Spectralis OCT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* willingness to comply with the protocol (4 visits)
* 41 - 80 years, informed consent
* acute N-AION (\< 7 d)
* D-BCVA \> 0.1 (2/20)
* RAPD ≥ 0.3 logE steps (neutral density filters) and:
* spherical ametropia max. ± 8 dpt, cylindrical ametropia max. ± 3 dpt
* isocoria, pupil diameter \> 3 mm

Exclusion Criteria

* diabetic retinopathy and any other orbital, intracranial or optic nerve disease
* history of epilepsy or significant psychiatric disease
* medications known to affect visual field sensitivity
* infections (e.g. keratitis, conjunctivitis, uveitis)
* severe dry eyes
* miotic drug
* amblyopia
* strabismus
* any ocular pathology, in either eye, that may interfere with the ability to obtain visual fields, disc imaging or accurate IOP readings
* cataract with relevant impairment of vision
* keratoconus
* intraocular surgery (except for uncomplicated cataract surgery) performed \< 3 month prior to screening
* history or signs of any visual pathway affection other than N-AION
* history or presence of macular disease and / or macular edema
* ocular trauma
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital Freiburg

OTHER

Sponsor Role collaborator

University Hospital Tuebingen

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ulrich Schiefer

Professor Dr. med. Ulrich Schiefer

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ulrich Schiefer, Prof.

Role: PRINCIPAL_INVESTIGATOR

Centre for Ophthalmology Institute for Ophthalmic Research University of Tübingen

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre for Ophthalmology Institute for Ophthalmic Research University of Tübingen

Tübingen, Baden-Wurttemberg, Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

References

Explore related publications, articles, or registry entries linked to this study.

Kernstock C, Beisse F, Wiethoff S, Mast A, Krapp E, Grund R, Dietzsch J, Lagreze W, Fischer D, Schiefer U. Assessment of functional and morphometric endpoints in patients with non-arteritic anterior ischemic optic neuropathy (NAION). Graefes Arch Clin Exp Ophthalmol. 2014 Mar;252(3):515-21. doi: 10.1007/s00417-014-2572-z. Epub 2014 Jan 31.

Reference Type RESULT
PMID: 24477537 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

73/2009B02

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.